Canadian Cannabis Edibles Company Completes First Australian Export, Generating $350,000 in Revenue

Sponsored:

Thursday, April 30, 2026

The global medical cannabis market is in a genuine expansion phase, with Australia emerging as an active and fast-growing market outside of North America. Since the country's regulatory framework matured in recent years, patient numbers and product diversity have increased significantly. Edibles, in particular, are attracting attention due to their precise dosing, longer shelf life, and familiar consumer format. The ability to export compliant, GMP-certified products from Canada into this international channel is becoming a meaningful competitive advantage.

For smaller Canadian operators, accessing international export opportunities requires overcoming barriers related to regulatory compliance, GMP certification, and securing credible partners. Today, one CSE-listed company announced it has cleared these hurdles, completing its first cannabis gummy export to Australia and generating C$350,000 in revenue.

Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) announced the successful completion of its first export of medical cannabis gummies to Australia. The products were produced in compliance with Canadian federal regulations and applicable GMP standards. The customer for this shipment is a top-three global cannabis company, which Herbal Dispatch states validates its positioning as a trusted supply partner in the international medical ecosystem.

The company anticipates additional follow-on shipments in 2026, subject to regulatory approvals and market demand. Herbal Dispatch currently maintains active export relationships across multiple international markets, including Australia, Portugal, Germany, Brazil, the Czech Republic, the United Kingdom, Switzerland, and Costa Rica. The successful Australia shipment represents tangible revenue proof of the company's international strategy in the edibles category.

CEO Philip Campbell stated that the milestone highlights the strength of the product offering and the ability to execute in regulated international markets, viewing it as a step toward scaling a high-margin export channel and establishing recurring international revenue streams.

Domestically, the company is also expanding its edibles lineup under the Chomp brand, targeting both medical and recreational channels. Herbal Dispatch's platform spans product development, distribution, and direct-to-consumer e-commerce, providing multiple touchpoints with end consumers.

HERB / LUFFF is trading at C$0.06 and US$0.0452, up 20.00% and 9.1%, respectively. At a market capitalization of $8 million, a single C$350,000 export shipment represents a significant revenue event. 

Sponsored: